PMC:7736111 / 4039-4336
Annnotations
LitCovid-PD-HP
{"project":"LitCovid-PD-HP","denotations":[{"id":"T4","span":{"begin":212,"end":232},"obj":"Phenotype"}],"attributes":[{"id":"A4","pred":"hp_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/HP_0002098"}],"text":"creased levels of proinflammatory IL-6 and an increase in the neutrophil/lymphocyte ratio (Liu T. et al., 2020; Tan L. et al., 2020b; Tan M. et al., 2020c). Between 3 and 17% of COVID-19 patients developed acute respiratory distress syndrome (ARDS), as a result of hyper inflammation (excessive in"}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"64","span":{"begin":34,"end":38},"obj":"Gene"},{"id":"75","span":{"begin":187,"end":195},"obj":"Species"},{"id":"85","span":{"begin":178,"end":186},"obj":"Disease"},{"id":"86","span":{"begin":206,"end":241},"obj":"Disease"},{"id":"87","span":{"begin":243,"end":247},"obj":"Disease"},{"id":"88","span":{"begin":265,"end":283},"obj":"Disease"}],"attributes":[{"id":"A64","pred":"tao:has_database_id","subj":"64","obj":"Gene:3569"},{"id":"A75","pred":"tao:has_database_id","subj":"75","obj":"Tax:9606"},{"id":"A85","pred":"tao:has_database_id","subj":"85","obj":"MESH:C000657245"},{"id":"A86","pred":"tao:has_database_id","subj":"86","obj":"MESH:D012128"},{"id":"A87","pred":"tao:has_database_id","subj":"87","obj":"MESH:D012128"},{"id":"A88","pred":"tao:has_database_id","subj":"88","obj":"MESH:D007249"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"creased levels of proinflammatory IL-6 and an increase in the neutrophil/lymphocyte ratio (Liu T. et al., 2020; Tan L. et al., 2020b; Tan M. et al., 2020c). Between 3 and 17% of COVID-19 patients developed acute respiratory distress syndrome (ARDS), as a result of hyper inflammation (excessive in"}